National Yang Ming Chiao Tung University

Other

Gene Research Lab. Co., Ltd.

Yi-Ming A Chen

Shih-Ping Liu

Kuan-Hsuan Chen

Ching-Ping Yang

Yi-Jen Liao

A remote editing card printing system by using mobile handsets includes a card printer for printing cards having a specific size. The card printer includes a transformer for transferring instructions into machine codes for instructing a printing unit of the card printer to print cards with predetermine drawings or texts on cards; A layout editor installed on the electronic computer device; the layout editor causing a user to input printing instructions or layout instructions through an I/O device of the electronic computer device to edit a layout of a card and thus causing the printing unit to print the cards based on the layout and printing instructions. The layout editor may be installed on an electronic computer device or a cloud device, and an APP is installed on a handset to be connected to the layout editor so that a user may edit the instructions directly on the APP, or the layout editor is installed on the handset directly.

Remote editing card printing system by using mobile handsets

The present invention is related to anti-NPC2 monoclonal antibodies, which against NPC2 or glycosylated-NPC2; and is related to a method of detecting fatty liver tissues, cancer cells or cancer tissues by evaluating the expression level of NPC2 or glycosylated-NPC2 in the cells or tissues.

Anti-NPC2 monoclonal antibodies and a method of detecting fatty liver tissue, cancer cells or cancer tissue by using them

The present invention relates to Glycine N-methyltransferase (GNMT) animal model and use thereof.

Mouse model for depression, schizophrenia and alzheimer's disease and the use thereof

The present invention is a new type of Glycine N-methyltransferase (GNMT) knockout mice model. This model can be applied to screen drug, test of treatment and search for diagnostic marker of hepatocellular carcinoma (HCC), glycogen storage disease, liver dysplasia, fatty liver and other liver disease.

Glycine N-methyltransferase (GNMT) animal model and use thereof

The present invention provides two unique monoclonal antibodies directed against a portion of the human Glycine N-methyltransferase, and methods of use for the monoclonal antibodies in detecting, monitoring and diagnosing malignancies characterized by down-regulation of expression or inappropriate expression of the Glycine N-methyltransferase.

Glycine N-methyltransferase monoclonal antibodies and methods of use therefor

The present invention relates to a method of detecting abnormalities of cells having decreased level of Glycine N-methyltransferase (GNMT) and to a method of correcting the abnormalities of cells.

Growing community of inventors

Taipei, Taiwan

Yi-Ming A Chen